Taking back control: The experience of adults using semaglutide and tirzepatide for obesity treatment - A qualitative study
The findings suggest the medications provide a sense of hope for effective treatment, facilitate dietary behavior change, and evoke quality of life benefits beyond weight loss. The patient-provider relationship and obesity knowledge of the physician are integral in discussing and acquiring the medications, yet patients initially learn about the medications outside the healthcare system.
Authors
- Fredrick Peters (ORCID: https://orcid.org/0000-0002-2134-0747)
- Lauren Lynn Trocchio
Institutions
- University of Technology Sydney (AU)
- Concordia University Chicago (US)
Publication Details
- Journal
- Obesity Pillars
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1016/j.obpill.2025.100237
- Citations
- 2
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.79